William G Whitford,
Life Science Strategic Solutions Leader,
DPS Group
Bill Whitford is Life Science Strategic Solutions Leader at DPS Group. Formerly Strategic Solutions Leader, BioProcess, Cytiva, formerly GE Healthcare Life Sciences in Logan, UT with over 20 years’ experience in biotechnology product and process development. He joined the company 16 years ago as a team leader in R&D developing products supporting biomass expansion, protein expression and virus secretion in mammalian and invertebrate cell lines. Products he has commercialized include defined and animal product-free hybridoma media, fed-batch supplements, and aqueous lipid dispersions. An invited lecturer at international conferences, Bill has published over 250 articles, book chapters and patents in several areas of bioproduction. He now enjoys such industry activities as serving on the editorial advisory board for BioProcess International.
The Biologicalisation of Medicine and Manufacturing
Tuesday, 18 August 2020 at 10:00
Add to Calendar ▼2020-08-18 10:00:002020-08-18 11:00:00Europe/LondonThe Biologicalisation of Medicine and Manufacturing3D-Printing and Biofabrication 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
The biologicalization (or the biological transformation) of
manufacturing is essentially the use of digital manufacturing approaches
(Industry 4.0) with biological and bio-inspired principles to support
more efficient and sustainable manufacturing. It creates a biomimetic
design – from reactions, equipment, and assemblies to materials,
processes, and facilities. For example, Nobel Prize winner Frances H.
Arnold invented systems directing the evolution of enzymes now routinely
used in development catalysts in manufacturing. This approach to
biologicalisation of processes is dependent upon advances in
biochemistry, many of the ‘omics, as well as genetic engineering. From
another direction, advances in fermentation and cell-culture
technologies is supplying a cell-based biologicalisation of processes.
Harmonization of digital principals with bio-integrated systems supports
processes composed not only of biological chemistries, but of
engineered organoids, tissues and cells. As supported by
nano/micro-technology, cell-based systems can enable the goals of
sustainability, economy and efficiency in research and therapeutics.
Add to Calendar ▼2020-08-17 00:00:002020-08-18 00:00:00Europe/London3D-Printing and Biofabrication 20203D-Printing and Biofabrication 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2020-08-18 10:00:002020-08-18 11:00:00Europe/LondonThe Biologicalisation of Medicine and Manufacturing3D-Printing and Biofabrication 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
